UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand
UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand
(Sharecast News) - Provexis announced on Monday that it has entered into a distribution agreement for its 'Fruitflow' heart health functional food ingredient in China, with a company set to act as distributor for 'Fruitflow+ Omega-3' under the Chinese cross-border e-commerce (CBEC) framework.
Provexis Inks Agreement For Fruitflow+ Omega-3 Distributor In China
UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise
Provexis To Purchase Inven2's Antihypertensive Patents
Provexis Interim Loss Narrows On Lower Costs, Revenue Growth
Provexis Raises GBP301,000 Through Share Placing For Working Capital
UK Shareholder Meetings Calendar - Next 7 Days
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------International up -
LONDON (Alliance News) - Provexis PLC on Friday hired Niamh O'Kennedy as chief scientific officer at the food supplement firm with immediate effect, and made a number of other adjustments to a
(Sharecast News) - Health foods outfit Provexis named Dr Niamh O'Kennedy as its new chief scientific officer on Friday.
(Sharecast News) - Provexis, the developer of a 'heart healthy' food additive, reported little movement in half-year losses despite a 56% increase in revenues.
LONDON (Alliance News) - Provexis PLC reported Thursday that a big rise in share-based payments led to a slightly widened loss for the 2018 financial year.However, Provexis said it has made
LONDON (Alliance News) - Provexis PLC reported Thursday that a big rise in share-based payments led to a slightly widened loss for the 2018 financial year.However, Provexis said it has made
LONDON (Alliance News) - Provexis PLC said Wednesday it appointed Frederic Boned as non-executive director with immediate effect.Currently, Boned is EMEA vice president of DSM's Human a